Crystal Pharmatech, a leading pharmaceutical technology company, has received the prestigious "Best Partner" award from Allorion Therapeutics for its exceptional services in supporting a First-in-Human (FIH) study. This recognition highlights Crystal Pharmatech's expertise and commitment to conducting polymorph screening, preformulation, and formulation development for new drug entities (NCE). In a ceremony held in May 2023, Dr. Zhen Liu presented commemorative trophies to Crystal Pharmatech's CRO and CDMO Business Units as a token of appreciation for their outstanding contributions and seamless collaboration with Allorion Therapeutics.